Life expectancy and health-adjusted life expectancy are decreased in people living with inflammatory bowel disease: a population-based matched cohort study
Introduction Inflammatory bowel disease (IBD) is a chronic immune-mediated disease of the gastrointestinal tract. Significant improvements in treatments for IBD have occurred in the past two decades. However, the benefits of new treatments on mortality is uncertain and no prior study has evaluated t...
Main Authors: | Ellen Kuenzig, Doug Manuel, Jessy Donelle, Eric Benchimol |
---|---|
Format: | Article |
Language: | English |
Published: |
Swansea University
2018-08-01
|
Series: | International Journal of Population Data Science |
Online Access: | https://ijpds.org/article/view/667 |
Similar Items
-
Real world evidence of the association between medication and life expectancy in elderly inflammatory bowel disease: a population-based cohort study
by: M. Ellen Kuenzig, et al.
Published: (2022-01-01) -
Impact of diabetes mellitus on life expectancy and health-adjusted life expectancy in Canada
by: Loukine Lidia, et al.
Published: (2012-04-01) -
Real age-adjusted life expectancy
by: Duncan Palmer, et al.
Published: (2013-04-01) -
Distributionally adjusted life expectancy as a life table function
by: Francisco Goerlich
Published: (2020-08-01) -
Adjusting for dependent comorbidity in the calculation of healthy life expectancy
by: Iburg Kim M, et al.
Published: (2006-04-01)